Supportive Care in Cancer

, Volume 16, Issue 2, pp 161–169

Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer

  • Stacey L. Hart
  • David M. Latini
  • Janet E. Cowan
  • Peter R. Carroll
  • CaPSURE™ Investigators
Original Article

Abstract

Goals of work

Fear of cancer recurrence (FOR) is common in prostate cancer patients, but little research has examined the impact of FOR on quality of life (QOL) or the mechanism by which these fears become intensified. The objective of this study was to examine treatment satisfaction (TS) as a moderator of the relationship between FOR and QOL.

Patients and methods

Data were drawn from the CaPSURE™ database, a 12,000-man national observational prostate cancer registry. Three hundred and thirty-three patients who underwent radical prostatectomy (RP) to treat their prostate cancer completed self-report measures. TS was measured 0–6 months post-RP with a nine-item scale developed for this study, FOR was measured 6–12 months post-RP with a previously validated five-item scale, and QOL was measured 12–18 months post-RP with the Short Form 36.

Main results

After controlling for age, education, number of comorbid medical conditions, and cancer severity, lower FOR (B = −0.12, p < 0.0001), higher TS (B = 0.09, p < 0.001), and the interaction of TS × FOR (B = 0.87, p < 0.05) significantly predicted higher mental health QOL scores. Furthermore, lower FOR (B = −0.08, p < 0.01), and the interaction of TS × FOR (B = −1.11, p < 0.01) significantly predicted higher physical health QOL scores.

Conclusions

TS levels mitigated the impact of high FOR on lower levels of QOL. Specifically, patients who reported lower TS and greater FOR endorsed significantly lower levels of QOL compared to other patients in the sample.

Keywords

Prostate cancer Treatment satisfaction Fear of recurrence Quality-of-life 

References

  1. 1.
    American Cancer Society (2007) Cancer facts and figures. American Cancer Society, Atlanta, GAGoogle Scholar
  2. 2.
    Bailey DE, Mishel MH, Belyea M, Stewart JL, Mohler J (2004) Uncertainty intervention for watchful waiting in prostate cancer. Cancer Nursing 27:339–346PubMedCrossRefGoogle Scholar
  3. 3.
    Bailey DE, Wallace M, Mishel MH (2007) Watching, waiting and uncertainty in prostate cancer. J Clin Nursing 16:734–741CrossRefGoogle Scholar
  4. 4.
    Dale W, Bilir P, Han M, Meltzer D (2005) The role of anxiety in prostate cancer: a structured review of the literature. Cancer 104:467–478PubMedCrossRefGoogle Scholar
  5. 5.
    D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280(11):969–974PubMedCrossRefGoogle Scholar
  6. 6.
    Deimling GT, Bowman KF, Sterns S, Wagner LJ, Kahana B (2006) Cancer-related health worries and psychological distress among older adult, long-term cancer survivors. Psycho-Oncology 15:306–330PubMedCrossRefGoogle Scholar
  7. 7.
    Germino BB, Mishel MH, Belyea M, Harris L, Ware A, Mohler J (1998) Uncertainty in prostate cancer: ethnic and family patterns. Cancer Practice 6:107–113PubMedCrossRefGoogle Scholar
  8. 8.
    Greenberg DB, Kornblith AB, Herndon JE, Zuckerman E, Schiffer CA, Weiss RB, Mayer RJ, Wolcok SM, Holland JC (1997) Quality of life for adult leukemia survivors treated on clinical trials of cancer and leukemia group B during the period 1971–1988. Cancer 80:1936–1944PubMedCrossRefGoogle Scholar
  9. 9.
    Hill JM, Kornblith AB, Jones D, Freeman A, Holland JF, Glicksman AS et al (1998) A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation. Cancer 82:208–218PubMedCrossRefGoogle Scholar
  10. 10.
    Humphris GM, Rogers S, McNally D, Lee-Jones C, Brown J, Vaughan D (2003) Fear of recurrence and possible causes of anxiety and depression in orofacial cancer patients. Int J Oral Maxillofac Surg 32:486–491PubMedCrossRefGoogle Scholar
  11. 11.
    Lee-Jones C, Humphris G, Dixon R, Hatcher MB (1997) Fear of cancer recurrence-A literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psycho-Oncology 6:95–105PubMedCrossRefGoogle Scholar
  12. 12.
    Lubeck DP, Litwin MS, Henning JM, Mathias SD, Bloor L, Carroll PR (2000) An instrument to measure patient satisfaction with healthcare in an observation database: results of a validation study using data from CaPSURE™. Am J Manag Care 6:70–76PubMedGoogle Scholar
  13. 13.
    Lubeck DP, Litwin MS, Henning JM, Stier DM, Mazonson P, Fisk R et al (1996) The CaPSURE™ database: a methodology for clinical practice and research in prostate cancer. CaPSURE™ Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 48:773–777PubMedCrossRefGoogle Scholar
  14. 14.
    Maliski SL, Kwan K, Krupski T, Fink A, Orecklin JR, Litwin MS (2004) Confidence in the ability to communicate with physicians among low-income patients with prostate cancer. Urology 64:329–334PubMedCrossRefGoogle Scholar
  15. 15.
    Mehta SS, Lubeck DP, Pasta DJ, Litwin MS (2003) Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: Results from CaPSURE™. J Urol 170:1931–1938PubMedCrossRefGoogle Scholar
  16. 16.
    Mellon S, Northouse LL, Weiss LK (2006) A population-based study of the quality of life of cancer survivors and their family caregivers. Cancer Nursing 29:120–131PubMedCrossRefGoogle Scholar
  17. 17.
    Mishel MH (1998) Uncertainty in illness. Image 20:225–232Google Scholar
  18. 18.
    Ong LML, Visser MRM, Lammes FB, de Haes JCJM (2000) Doctor-patient communication and cancer patients’ quality of life and satisfaction. Patient Educ Couns 41:145–156PubMedCrossRefGoogle Scholar
  19. 19.
    Partin AW, Pound CR, Clemens JQ, Epstein JI, Walsh PC (1993) Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol Clin North Am 20:713–725PubMedGoogle Scholar
  20. 20.
    Roth A, Nelson CJ, Rosenfeld B, Warshowski A, O’Shea N, Scher H, Holland JC, Slovin S, Curley-Smart T, Reynolds T, Breitbart W (2006) Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Psychosomatics 47:340–347PubMedCrossRefGoogle Scholar
  21. 21.
    Vickberg SM (2003) The concerns about recurrence scale (CARS): a systematic measure of women’s fears about the possibility of breast cancer recurrence. Ann Behav Med 25:16–24PubMedCrossRefGoogle Scholar
  22. 22.
    Von Essen L, Larsson G, Oberg K, Sjoden PO (2002) “Satisfaction with care”: associations with health-related quality of life and psychosocial function among Swedish patients with endocrine gastrointestinal tumours. Eur J Cancer Care 11:91–99CrossRefGoogle Scholar
  23. 23.
    Wallace M (2003) Uncertainty and quality of life of older men who undergo watchful waiting for prostate cancer. Oncol Nurs Forum 30:303–309PubMedCrossRefGoogle Scholar
  24. 24.
    Ware JE Jr, Losinski M (2001) The SF-36 physical & mental health summary scales: a manual for users of version 1, 2nd edn. QualityMetric, Lincoln, RIGoogle Scholar
  25. 25.
    Wyatt G, Kurtz ME, Liken M (1993) Breast cancer survivors: an exploration of quality of life issues. Cancer Nursing 16:440–448PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Stacey L. Hart
    • 1
    • 2
  • David M. Latini
    • 3
    • 4
  • Janet E. Cowan
    • 5
    • 6
  • Peter R. Carroll
    • 5
    • 6
  • CaPSURE™ Investigators
  1. 1.Department of PsychologyRyerson UniversityTorontoCanada
  2. 2.Ryerson UniversityTorontoCanada
  3. 3.Scott Department of Urology and the Dan L. Duncan Cancer CenterBaylor College of MedicineHoustonUSA
  4. 4.The Houston Center for Quality of Care and Utilization StudiesVA Medical CenterHoustonUSA
  5. 5.Department of UrologyUniversity of California San FranciscoSan FranciscoUSA
  6. 6.Programs in Urologic Oncology and Genitourinary Cancer Epidemiology and Population ScienceComprehensive Cancer Center, University of California San FranciscoSan FranciscoUSA

Personalised recommendations